ReSeed Raises $4.6 Million to Expand Climate Financing for Social Impact

ReSeed Raises .6 Million to Expand Climate Financing for Social Impact

ReSeed, an AI-powered provider of regenerative nature-based services, has announced a successful seed round of $4.6 million, led by One Small Planet, with participation from Thorn Partners and angel investors, including Baratunde Thurston and Elizabeth Stewart. This funding will support ReSeed’s expansion into the commercial market. ReSeed offers a globally scalable climate solution with significant … Read more

Bold Raises $17 Million Series A to Further Accelerate Growth

Bold Raises  Million Series A to Further Accelerate Growth

Bold, a healthy aging platform, has secured $17 million in Series A funding led by Rethink Impact, with participation from Samsung Next and existing investors Andreessen Horowitz (a16z) Bio + Health, Khosla Ventures, GingerBread Capital, and Primetime Partners. The company’s total funding now stands at $27 million. Bold offers personalized, evidence-based exercise programs designed to … Read more

Usage.AI, A Cloud Savings Leader Raises $9 Million VC Financing Round

Usage.AI, A Cloud Savings Leader Raises  Million VC Financing Round

Usage.AI, a company specializing in identifying cloud savings, has raised $9 million in a funding round led by Amity Ventures, with participation from existing investors TenVC, JAM Fund, and Backend Capital. The company, which launched less than 18 months ago, provides a platform that helps businesses save money on their cloud spending. Usage.AI’s platform has … Read more

Nine Square Therapeutics Awarded $4.5 Million Grant

Nine Square Therapeutics Awarded .5 Million Grant

Nine Square Therapeutics, a biotechnology company focused on discovering novel small molecules to treat severe neurodegenerative diseases, has been awarded a $4.5 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The grant will be used to accelerate the development of novel Parkin activators for the treatment of Parkinson’s disease (PD). … Read more

2seventy bio lays off 176 employees

2seventy bio lays off 176 employees

Biopharmaceutical company 2seventy bio Inc. is laying off 176 employees, which amounts to approximately 40% of its total workforce. This significant reduction in staff comes as the company also announced that its CEO, Nick Leschly, who has been in the role since 2seventy split off from bluebird bio Inc. in 2021, will be stepping down. … Read more

CertifID Raises $20 Million in Series B Funding to Combat Real Estate Fraud

CertifID Raises  Million in Series B Funding to Combat Real Estate Fraud

CertifID, a prominent wire fraud protection company, has secured $20 million in new funding through a Series B round led by Arthur Ventures, the same investor that participated in CertifID’s $12.5 million Series A round in May 2022. CertifID has experienced strong adoption of its wire fraud protection software, insurance, and recovery services over the … Read more

Enfabrica Secures $125 Million in Series B Financing to Advance AI Infrastructure Networking Chips

Enfabrica Secures 5 Million in Series B Financing to Advance AI Infrastructure Networking Chips

Enfabrica Corporation, a rapidly growing startup specializing in converged networking and memory fabric silicon and software for the demands of artificial intelligence (AI) and accelerated computing workloads, has successfully concluded a Series B financing round, raising a substantial $125 million. Led by Atreides Management, the oversubscribed round significantly boosts Enfabrica’s valuation, which now exceeds five … Read more

Renibus Therapeutics Successfully Closes Upsized Series B Financing, Totaling $72 Million

Renibus Therapeutics Successfully Closes Upsized Series B Financing, Totaling  Million

Renibus Therapeutics, a clinical-stage biopharmaceutical firm with a focus on preventing and treating cardio-renal and metabolic diseases, has announced the completion of an extension to its Series B financing round, raising a total of $72 million. The company’s investors include both existing and new stakeholders, including prominent figures in the cardiac surgery community. The additional … Read more